Semi-Annual Consolidated Balance Sheet

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,120,000,000 JPY
8,014,000,000 JPY
Other
834,000,000 JPY
568,000,000 JPY
Current assets
44,947,000,000 JPY
43,219,000,000 JPY
Non-current assets
Property, plant and equipment
24,427,000,000 JPY
23,763,000,000 JPY
Property, plant and equipment
Land
8,818,000,000 JPY
8,818,000,000 JPY
Construction in progress
246,000,000 JPY
1,669,000,000 JPY
Other
15,000,000 JPY
JPY
Intangible assets
Other
200,000,000 JPY
273,000,000 JPY
Intangible assets
600,000,000 JPY
329,000,000 JPY
Investments and other assets
5,826,000,000 JPY
5,153,000,000 JPY
Investments and other assets
Investment securities
3,924,000,000 JPY
3,018,000,000 JPY
Deferred tax assets
396,000,000 JPY
678,000,000 JPY
Other
1,232,000,000 JPY
1,307,000,000 JPY
Non-current assets
30,854,000,000 JPY
29,246,000,000 JPY
Assets
75,802,000,000 JPY
72,466,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
2,350,000,000 JPY
2,350,000,000 JPY
Income taxes payable
270,000,000 JPY
426,000,000 JPY
Other
3,751,000,000 JPY
4,086,000,000 JPY
Current liabilities
29,650,000,000 JPY
28,474,000,000 JPY
Non-current liabilities
Long-term borrowings
7,021,000,000 JPY
5,747,000,000 JPY
Asset retirement obligations
108,000,000 JPY
108,000,000 JPY
Other
153,000,000 JPY
123,000,000 JPY
Non-current liabilities
9,489,000,000 JPY
8,343,000,000 JPY
Liabilities
39,140,000,000 JPY
36,817,000,000 JPY
Provision for retirement benefits for directors (and other officers)
153,000,000 JPY
168,000,000 JPY
Provision for bonuses
922,000,000 JPY
930,000,000 JPY
Deferred tax liabilities for land revaluation
1,315,000,000 JPY
1,315,000,000 JPY
Provision for bonuses for directors (and other officers)
20,000,000 JPY
21,000,000 JPY
Net assets
Shareholders' equity
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
Capital surplus
14,951,000,000 JPY
15,009,000,000 JPY
Retained earnings
16,541,000,000 JPY
15,811,000,000 JPY
Treasury shares
-2,588,000,000 JPY
-2,173,000,000 JPY
Shareholders' equity
39,662,000,000 JPY
39,405,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
1,634,000,000 JPY
879,000,000 JPY
Revaluation reserve for land
-4,635,000,000 JPY
-4,635,000,000 JPY
Valuation and translation adjustments
-3,000,000,000 JPY
-3,756,000,000 JPY
Net assets
39,662,000,000 JPY
10,000,000,000 JPY
14,951,000,000 JPY
5,300,000,000 JPY
-2,588,000,000 JPY
16,541,000,000 JPY
1,634,000,000 JPY
-3,000,000,000 JPY
4,951,000,000 JPY
-4,635,000,000 JPY
10,758,000,000 JPY
36,661,000,000 JPY
11,241,000,000 JPY
10,758,000,000 JPY
10,511,000,000 JPY
5,300,000,000 JPY
5,009,000,000 JPY
-3,756,000,000 JPY
35,649,000,000 JPY
15,009,000,000 JPY
-4,635,000,000 JPY
10,000,000,000 JPY
-2,173,000,000 JPY
39,405,000,000 JPY
879,000,000 JPY
15,811,000,000 JPY
10,000,000,000 JPY
-2,170,000,000 JPY
5,300,000,000 JPY
14,731,000,000 JPY
838,000,000 JPY
5,009,000,000 JPY
10,758,000,000 JPY
-3,796,000,000 JPY
-4,635,000,000 JPY
34,532,000,000 JPY
9,431,000,000 JPY
15,009,000,000 JPY
38,329,000,000 JPY
Liabilities and net assets
75,802,000,000 JPY
72,466,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.